Welcome
Dear Colleagues,
It is our great pleasure to invite basic scientists and clinicians interested in the field of fibrinolysis and proteolysis to the XIXth Congress of the International Society for Fibrinolysis and Proteolysis to be held from July 6th to July 10th 2008 in Vienna, which was host to this meeting already in 1986. This makes Vienna the first and only city to which the Congress of the International Society for Fibrinolysis has returned. We feel that this is not without a reason. Vienna offers much to the international visitor. It has a rich cultural heritage, can be easily reached, has a modern infrastructure and last but not least is a very safe place. Taken together, these facts rank Vienna among the most liveable cities in the world.
As basic science and clinical investigations critically depend on each other and combined efforts are necessary to develop new strategies for the prevention and treatment of numerous diseases to which components of the fibrinolytic system, proteases, their inhibitors, receptors and cofactors contribute, we see our meeting as a forum for basic research and its translation into the clinical setting. Proteases and inhibitors play key roles in the development and progression of cardiovascular disease, obesity, diabetes, cancer, neurologic disease, inflammation and embryonic development. Therefore it will be our major aim to organize this meeting at the interphase of basic and clinical research thereby integrating basic and clinical research aspects in order to attract basic scientists as well as cardiologists, neurologists and haematologists/oncologists. We hope that this approach will allow critical discussions and a fruitful exchange of ideas between these groups, which ultimately should lead to improve our strategies in combating the diseases mentioned above.
We look forward to welcoming you and your colleagues in the beautiful city of Vienna in July 2008.
Yours sincerely,
Johann Wojta (President)
Kurt Huber (Vice President)
Bernd R. Binder (Chairman of the Programme Committee)
It is our great pleasure to invite basic scientists and clinicians interested in the field of fibrinolysis and proteolysis to the XIXth Congress of the International Society for Fibrinolysis and Proteolysis to be held from July 6th to July 10th 2008 in Vienna, which was host to this meeting already in 1986. This makes Vienna the first and only city to which the Congress of the International Society for Fibrinolysis has returned. We feel that this is not without a reason. Vienna offers much to the international visitor. It has a rich cultural heritage, can be easily reached, has a modern infrastructure and last but not least is a very safe place. Taken together, these facts rank Vienna among the most liveable cities in the world.
As basic science and clinical investigations critically depend on each other and combined efforts are necessary to develop new strategies for the prevention and treatment of numerous diseases to which components of the fibrinolytic system, proteases, their inhibitors, receptors and cofactors contribute, we see our meeting as a forum for basic research and its translation into the clinical setting. Proteases and inhibitors play key roles in the development and progression of cardiovascular disease, obesity, diabetes, cancer, neurologic disease, inflammation and embryonic development. Therefore it will be our major aim to organize this meeting at the interphase of basic and clinical research thereby integrating basic and clinical research aspects in order to attract basic scientists as well as cardiologists, neurologists and haematologists/oncologists. We hope that this approach will allow critical discussions and a fruitful exchange of ideas between these groups, which ultimately should lead to improve our strategies in combating the diseases mentioned above.
We look forward to welcoming you and your colleagues in the beautiful city of Vienna in July 2008.
Yours sincerely,
Johann Wojta (President)
Kurt Huber (Vice President)
Bernd R. Binder (Chairman of the Programme Committee)